ARTO

"It isn't just another conference where you sit and listen to presentations and others talking." What makes the new CPHI Sustainability Summit different from every other conference? On the latest episode of Making It In Manufacturing, Thomas McMann put that question to Silvia Forroova, Director of Partnerships and Sustainability at CPHI Milan. Silvia explains that the summit is a two-day collaborative platform, designed for pharmaceutical professionals committed to accelerating sustainable transformation across the entire value chain. It runs alongside CPHI Milan as part of Informa Markets' flagship pharma event, and it's built around meaningful dialogue rather than presentations. Watch Thomas and Silvia's full conversation on our YouTube channel and Spotify. Link in the comments below 👇 ARTO is the Official Content Partner for CPHI Milan 2026, 6-8 October, Fiera Milano. For 10% off your CPHI Milan ticket, use code: ASMP671515

"A year's worth of business in three days." That is how Tara Dougal, Event Director for CPHI Milan, describes what the show offers the people who walk through the door. Sixty thousand attendees. The entire pharmaceutical supply chain under one roof, from raw ingredients and APIs through to packaging and drug delivery. The clients you have worked with for thirty years, and the ones you have not met yet. Three days that are worth a year. The full episode of Making it in Manufacturing is out now. Watch now! https://lnkd.in/e6bmvHeV ARTO is the Official Content Partner for CPHI Milan 2026, 6-8 October, Fiera Milano. For 10% off your CPHI Milan ticket use codeASMP671515.

ARTO has a huge announcement to share. We are the Official Podcast Partner for CPHI Milan 2026. 6–8 October, Fiera Milano. Across the partnership we will bring exciting and fresh content highlighting the importance CPHI brings to the lives of patients. We are filming a brand new season of Making it in Manufacturing, hosted by Thomas McMann, and featuring some of the biggest names in the industry. Alongside it, a live panel, the Newsbeat stage documented in full, boots-on-the-ground mini interviews from the floor, and a great deal more. Going to Milan? Let us know in the comments, we would love to send you an invite to our events!

HUGE news for ARTO's Making it in Manufacturing Podcast..... I'm very proud to share that we have partnered with CPHI Milan to be their official podcast partner for the upcoming European conference in Milan next month. We have some exciting guests lined up, as well as a panel discussion to share and a new style of content brought to you directly from the conference floor! If you attending the conference drop a comment below and we can try to connect over the 3 days.

What does it take to transform a biologics manufacturing business into a global CDMO leader while keeping culture, transparency and patient impact at the centre of every decision? This week on Making It In Manufacturing, Thomas McMann sat down with Lars Petersen, CEO of FUJIFILM Biotechnologies, with more than 30 years of experience spanning biologics manufacturing, engineering, operations leadership, global site leadership and biotech innovation across Novo Nordisk, Genentech, Roche and Biogen. In this episode, Lars covers: • Why “Partners for Life” became the foundation of Fujifilm Biotechnologies’ long-term customer strategy and how transparency reshaped CDMO partnerships • How personal loss, engineering curiosity and early leadership experiences at Novo Nordisk shaped Lars’ approach to people, manufacturing and patient impact • Lessons from the California biotech ecosystem at Genentech and Roche, including how culture and scientific purpose influenced leadership philosophy • How the KojoX modular manufacturing platform is helping reduce engineering timelines, improve scalability and rethink biologics facility design • Why AI will transform pharmaceutical manufacturing and how Fujifilm Biotechnologies is preparing the next evolution of biologics production Lars shares an honest perspective on leadership, scaling culture globally, operational excellence and the future of biologics manufacturing. For anyone working across biotech, pharma manufacturing, CDMOs or advanced therapies, this conversation offers a rare look into the mindset behind one of the industry’s fastest-growing organisations. To listen to (or watch) the full episode, click on the first link in the comments below

What does it actually take to deliver a pharmaceutical facility project without it going off the rails? This week on Making It In Manufacturing, Thomas McMann sat down with Bruce Klopfenstein, Project Manager at GSK, with over 30 years of experience spanning project management, engineering, validation, EPC consulting, and client-side leadership across companies including Jacobs, Johnson & Johnson, FUJIFILM Biotechnologies and IBM. In this episode, Bruce covers: - Why getting ACV engaged at the very start of a project changes everything, and why the industry has been slow to do it. - Who is actually responsible when a pharmaceutical project goes over budget, and why change control is almost always at the root of it. - The $100,000 mistake that came down to a missing piece of paper, and the engineer who had to fly to Europe during Covid to fix it. - How GSK is leading a major sustainability push through its low-carbon inhaler propellant project in France, and why 49% of their total annual emissions trace back to a single product type. - Why AI adoption in pharmaceutical validation is no longer optional, and how companies like GSK and Eli Lilly and Company are already using it inside the firewall, with Bruce's take on Valkit.ai and what large language models can do for protocol generation at scale. This is a genuinely experienced perspective on what it takes to manage complex pharmaceutical projects, and what the industry needs to do differently. To listen to (or watch) the full episode, search "Making it in Manufacturing - Bruce Klopfenstein" on wherever you get your podcasts, or click on the first link in the comments below.